More about Ibudilast, this time from Neurology Today:
Source: http://journals.lww.com/neurotodayonlin ... ?PostID=24
[...] Researchers reported that brain atrophy measured by the difference in the slope of brain parenchymal fraction was decreased by 48 percent among patients treated with ibudilast — a reduction of 0.00105 among patients on the drug — compared with a reduction of 0.00202 among those on placebo from baseline to week 96.
More about Ibudilast
-
- Similar Topics
- Replies
- Views
- Last post